MedPath

长风药业股份有限公司

Ownership
-
Established
2013-01-24
Employees
-
Market Cap
-
Website
http://www.cfpharmtech.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

5

NMPA:5

Drug Approvals

Formoterol Fumarate Inhalation Solution

Product Name
富马酸福莫特罗吸入溶液
Approval Number
国药准字H20253076
Approval Date
Jan 8, 2025
NMPA

Terbutaline Sulfate Nebuliser Solution

Product Name
硫酸特布他林雾化吸入用溶液
Approval Number
国药准字H20234102
Approval Date
Sep 5, 2023
NMPA

Azelastine Hydrochloride and Fluticasone Propionate Nasal Spray

Product Name
氮䓬斯汀氟替卡松鼻喷雾剂
Approval Number
国药准字H20223778
Approval Date
Nov 1, 2022
NMPA

Salbutamol Sulfate Inhalation Solution

Product Name
吸入用硫酸沙丁胺醇溶液
Approval Number
国药准字H20213807
Approval Date
Oct 26, 2021
NMPA

Budesonide Suspension for Inhalation

Product Name
吸入用布地奈德混悬液
Approval Number
国药准字H20213357
Approval Date
May 11, 2021
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.